These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20625868)

  • 21. Translational research: the changing landscape of drug discovery.
    Fishburn CS
    Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational research and the evolving landscape for biomedical innovation.
    Kaitin KI
    J Investig Med; 2012 Oct; 60(7):995-8. PubMed ID: 22918200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing New Treatments for Heart Failure: Focus on the Heart.
    Gheorghiade M; Larson CJ; Shah SJ; Greene SJ; Cleland JG; Colucci WS; Dunnmon P; Epstein SE; Kim RJ; Parsey RV; Stockbridge N; Carr J; Dinh W; Krahn T; Kramer F; Wahlander K; Deckelbaum LI; Crandall D; Okada S; Senni M; Sikora S; Sabbah HN; Butler J
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry-Academic Relationship in a New Era of Drug Discovery.
    Vallance P
    J Clin Oncol; 2016 Oct; 34(29):3570-3575. PubMed ID: 27458309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: yes.
    Havrdová E
    Mult Scler; 2012 Sep; 18(9):1209-10. PubMed ID: 22936682
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.
    Wong EH; Yocca F; Smith MA; Lee CM
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1269-84. PubMed ID: 20716397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using patent data to assess the value of pharmaceutical innovation.
    Kesselheim AS; Avorn J
    J Law Med Ethics; 2009; 37(2):176-83. PubMed ID: 19493065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Academic drug discovery: current status and prospects.
    Everett JR
    Expert Opin Drug Discov; 2015; 10(9):937-44. PubMed ID: 26088126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Academic-industry Collaborations in Translational Stroke Research.
    Boltze J; Wagner DC; Barthel H; Gounis MJ
    Transl Stroke Res; 2016 Aug; 7(4):343-53. PubMed ID: 27301976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical pipeline.
    Lowen T
    Minn Med; 2011 Oct; 94(10):16-8. PubMed ID: 23256279
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.
    Gromo G; Mann J; Fitzgerald JD
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leveraging model-informed approaches for drug discovery and development in the cardiovascular space.
    Dockendorf MF; Vargo RC; Gheyas F; Chain ASY; Chatterjee MS; Wenning LA
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):355-364. PubMed ID: 29353335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting translational research in academic health centers: navigating the "roadmap".
    Cripe TP; Thomson B; Boat TF; Williams DA
    Acad Med; 2005 Nov; 80(11):1012-8. PubMed ID: 16249299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creative cross-organizational collaboration: coming to a project near you.
    Reeve BC
    Regen Med; 2012 Mar; 7(2):237-43. PubMed ID: 22236251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to develop therapeutic and translational research collaborations with industry.
    Kleiman RJ; Ehlers MD
    Mol Biol Cell; 2019 Oct; 30(22):2741-2743. PubMed ID: 31609671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addressing the right targets in oncology: challenges and alternative approaches.
    Stock JK; Jones NP; Hammonds T; Roffey J; Dillon C
    J Biomol Screen; 2015 Mar; 20(3):305-17. PubMed ID: 25614505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opinion reflections on my presidency of UMDNJ.
    Cook SD
    N J Med; 2004 May; 101(5):56, 55. PubMed ID: 15185521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.